A publicly owned pharmaceutical industry is the best solution to stopping drug shortages.
by Dana Brown and Christopher Morten, Stat
Drug shortages in the United States are at a record high. At least 14 essential generic cancer drugs are currently in shortage, forcing patients and doctors to make difficult decisions to delay or ration first-line treatments, or accept second-best treatments. ADHD treatments, antibiotics, children’s acetaminophen, and many other critical medicines are also in short supply.
But most of the solutions being discussed are just Band-Aids on a broken system. They would do nothing to transform the incentives that routinely produce shortages and other market failures.
What we really need — for the health of our economy and society — is a robust public option in pharmaceuticals that produces and distributes essential medicines, such as cancer treatments. Publicly accountable public agencies can assure resilient supply chains and offer medicines at or even below cost, because keeping people healthy without bankrupting them in the process is good for society (and cost-effective to boot). This already happens at scales large and small all over the world, including Brazil, Sweden, Cuba, the U.K., India, Thailand, and more.
Recent Posts
ICE Sued Over ‘Civil Rights Catastrophe’ at West Texas Concentration Camp
Take Action Now “The conditions here in this ICE tent camp in a desert are inhumane and cruel,” said one Cameroonian plaintiff in the suit. “No human…
Tragedy and Potential: The Non-Proliferation Treaty Review Conference
Take Action Now The U.S.’s short, very general, poorly proofread statement on the conference outcome reflected a lack of interest in or familiarity…
California Democrats Keep Selling “Medicare for All” — While Protecting the System That Profits From Sickness
Take Action Now Gov. Gavin Newsom embodies that contradiction more than anyone.By Joshua Scheer, ScheerPost For nearly a decade, California…
Congress Quietly Moves to Integrate U.S. and Israeli Militaries
Take Action Now In the first step towards shifting aid further into the shadows, the House’s 2027 NDAA would all but fuse the two…